Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Wei

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Singapore Medical Journal|September 30, 2025
Severe tinnitus: how can we approach it?Gary Jek Chong Lee, Jasmine Jek Peng Liew, Andrew Wei Li Teng
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2013
Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patientsChindu Govindaraj, Peter Tan, Patricia Walker, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Patient Perceived Financial Burden in Haematological Malignancies: A Systematic ReviewCatriona Parker, Danielle Berkovic, Darshini Ayton, et al.
Leukemia & Lymphoma|September 1, 2023
Consecutive day dosing of high-dose cytarabine consolidation over 3 days is resource-efficient and safe in older adult patients with acute myeloid leukemiaRithin Nedumannil, Emily Batterham, Emily Harding, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 22, 2013
Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinicRuth Chieng, John Coutsouvelis, Susan Poole, et al.
Pediatric Nephrology (Berlin, Germany)|April 12, 2018
Correction to: Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow up of primary hyperoxaluria type IIIAda Ventzke, Markus Feldkötter, Andrew Wei, et al.
Pediatric Nephrology (Berlin, Germany)|July 17, 2017
Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type IIIAda Ventzke, Markus Feldkötter, Andrew Wei, et al.
Journal of Patient Safety|March 18, 2017
The Patients' Perspective: Hematological Cancer Patients' Experiences of Adverse Events as Part of CareJamie Bryant, Mariko Carey, Rob Sanson-Fisher, et al.
American Journal of Hematology|April 24, 2014
Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patientsChindu Govindaraj, Mutsa Madondo, Ying Ying Kong, et al.
Ejhaem|June 19, 2024
CD34-TdT-B-ALL masquerading as Burkitt lymphomaManu Juneja, Andrew Wei, Kylie Mason, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Singapore Medical Journal|September 30, 2025
Severe tinnitus: how can we approach it?Gary Jek Chong Lee, Jasmine Jek Peng Liew, Andrew Wei Li Teng
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2013
Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patientsChindu Govindaraj, Peter Tan, Patricia Walker, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Patient Perceived Financial Burden in Haematological Malignancies: A Systematic ReviewCatriona Parker, Danielle Berkovic, Darshini Ayton, et al.
Leukemia & Lymphoma|September 1, 2023
Consecutive day dosing of high-dose cytarabine consolidation over 3 days is resource-efficient and safe in older adult patients with acute myeloid leukemiaRithin Nedumannil, Emily Batterham, Emily Harding, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 22, 2013
Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinicRuth Chieng, John Coutsouvelis, Susan Poole, et al.
Pediatric Nephrology (Berlin, Germany)|April 12, 2018
Correction to: Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow up of primary hyperoxaluria type IIIAda Ventzke, Markus Feldkötter, Andrew Wei, et al.
Pediatric Nephrology (Berlin, Germany)|July 17, 2017
Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type IIIAda Ventzke, Markus Feldkötter, Andrew Wei, et al.
Journal of Patient Safety|March 18, 2017
The Patients' Perspective: Hematological Cancer Patients' Experiences of Adverse Events as Part of CareJamie Bryant, Mariko Carey, Rob Sanson-Fisher, et al.
American Journal of Hematology|April 24, 2014
Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patientsChindu Govindaraj, Mutsa Madondo, Ying Ying Kong, et al.
Ejhaem|June 19, 2024
CD34-TdT-B-ALL masquerading as Burkitt lymphomaManu Juneja, Andrew Wei, Kylie Mason, et al.
Pageof 10